Detalles de la búsqueda
1.
Efficacy of front-line treatment for hormone receptor-positive HER2-negative metastatic breast cancer with germline BRCA1/2 mutation.
Br J Cancer
; 128(11): 2072-2080, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37012318
2.
Enrollment of older metastatic breast cancer patients in first-line clinical trials: 9-year experience of the large-scale real-life multicenter French ESME cohort.
Breast Cancer Res Treat
; 191(3): 577-587, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34984582
3.
Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG network.
Gynecol Oncol
; 158(3): 666-672, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32624235
4.
The French national network dedicated to rare gynecological cancers diagnosis and management could improve the quality of surgery in daily practice of granulosa cell tumors. A TMRG and GINECO group Study.
Gynecol Oncol
; 157(1): 78-84, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32131977
5.
Alpelisib and fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the French early access program.
Oncogene
; 42(23): 1951-1956, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36611120
6.
MOVIE: a phase I, open-label, multicenter study to evaluate the safety and tolerability of metronomic vinorelbine combined with durvalumab plus tremelimumab in patients with advanced solid tumors.
ESMO Open
; 7(6): 100646, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36521418
7.
Metastatic inflammatory breast cancer: survival outcomes and prognostic factors in the national, multicentric, and real-life French cohort (ESME).
ESMO Open
; 6(4): 100220, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34303929
8.
Borderline ovarian tumors: Guidelines from the French national college of obstetricians and gynecologists (CNGOF).
Eur J Obstet Gynecol Reprod Biol
; 256: 492-501, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33262005
9.
BMS-690514, a VEGFR and EGFR tyrosine kinase inhibitor, shows anti-tumoural activity on non-small-cell lung cancer xenografts and induces sequence-dependent synergistic effect with radiation.
Br J Cancer
; 103(3): 347-53, 2010 Jul 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-20628392
10.
Why do residents choose the medical oncology specialty? Implications for future recruitment--results of the 2007 French Association of Residents in Oncology (AERIO) Survey.
Ann Oncol
; 21(1): 161-5, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19628567
11.
[Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Diagnosis and Management of Recurrent Borderline Ovarian Tumours]. / Tumeurs frontières de l'ovaire. Recommandations pour la pratique clinique du CNGOF Diagnostic et prise en charge des récidives.
Gynecol Obstet Fertil Senol
; 48(3): 314-321, 2020 03.
Artículo
en Francés
| MEDLINE | ID: mdl-32004781
12.
[Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Epidemiology and Risk Factors of Relapse, Follow-up and Interest of a Completion Surgery]. / Tumeurs frontières de l'ovaire. Recommandations pour la pratique clinique du CNGOF Épidémiologie et facteurs de risques de récidive, modalités de surveillance et intérêt d'une chirurgie de clôture.
Gynecol Obstet Fertil Senol
; 48(3): 248-259, 2020 03.
Artículo
en Francés
| MEDLINE | ID: mdl-32004784
13.
[Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Short Text]. / Tumeurs frontières de l'ovaire. Recommandations pour la pratique clinique du CNGOF Texte court.
Gynecol Obstet Fertil Senol
; 48(3): 223-235, 2020 03.
Artículo
en Francés
| MEDLINE | ID: mdl-32004780
14.
[Medical treatment in ovarian cancers newly diagnosed: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa]. / Traitements médicaux des cancers de l'ovaire lors de la prise en charge initiale. Article rédigé sur la base de la recommandation nationale de bonnes pratiques cliniques en cancérologie intitulée « Conduites à tenir initiales devant des patientes atteintes d'un cancer épithélial de l'ovaire ¼ élaborée par FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY sous l'égide du CNGOF et labellisée par l'INCa.
Gynecol Obstet Fertil Senol
; 47(2): 222-237, 2019 02.
Artículo
en Francés
| MEDLINE | ID: mdl-30709790
15.
Management of epithelial cancer of the ovary, fallopian tube, primary peritoneum. Long text of the joint French clinical practice guidelines issued by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY, endorsed by INCa. (Part 2: systemic, intraperitoneal treatment, elderly patients, fertility preservation, follow-up).
J Gynecol Obstet Hum Reprod
; 48(6): 379-386, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30936025
16.
Management of epithelial cancer of the ovary, fallopian tube, and primary peritoneum. Long text of the Joint French Clinical Practice Guidelines issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and endorsed by INCa. Part 1: Diagnostic exploration and staging, surgery, perioperative care, and pathology.
J Gynecol Obstet Hum Reprod
; 48(6): 369-378, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30936027
17.
[Part II drafted from the short text of the French guidelines entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY and endorsed by INCa. (Systemic and intraperitoneal treatment, elderly, fertility preservation, follow-up)]. / Partie 2 rédigée à partir de la synthèse de la recommandation nationale de bonnes pratiques cliniques intitulée « Conduites à tenir initiales devant des patientes atteintes d'un cancer épithélial de l'ovaire ¼ élaborée par FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY et labélisée par l'INCa. (Traitement systémique et intrapéritonéal, personnes âgées, préservation de la fertilité et suivi).
Gynecol Obstet Fertil Senol
; 47(2): 111-119, 2019 02.
Artículo
en Francés
| MEDLINE | ID: mdl-30704955
18.
[Part I drafted from the short text of the French Guidelines entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY and endorsed by INCa. (Diagnosis management, surgery, perioperative care, and pathological analysis)]. / Partie 1 rédigée sur la base de la recommandation nationale de bonnes pratiques cliniques en cancérologie intitulée « Conduites à tenir initiales devant des patientes atteintes d'un cancer épithélial de l'ovaire ¼ élaborée par FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY et labélisée par l'INCa. (Explorations diagnostiques et bilan d'extension, chirurgie, soins périopératoires et anatomopathologie).
Gynecol Obstet Fertil Senol
; 47(2): 100-110, 2019 02.
Artículo
en Francés
| MEDLINE | ID: mdl-30686724
19.
Management of epithelial cancer of the ovary, fallopian tube, and primary peritoneum. Short text of the French Clinical Practice Guidelines issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and endorsed by INCa.
Eur J Obstet Gynecol Reprod Biol
; 236: 214-223, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30905627
20.
Survival and reproductive function of 52 women treated with surgery and bleomycin, etoposide, cisplatin (BEP) chemotherapy for ovarian yolk sac tumor.
Ann Oncol
; 19(8): 1435-1441, 2008 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-18408223